Interferences in immunoassays: Mechanisms and outcomes in endocrinology;Interférences dans les immunodosages : mécanismes et conséquences en endocrinologie

Annales d'Endocrinologie

Volumn 69, Issue 5, 2008, Pages 415-425

  Sapin, R ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

Autoantibody; Heterophilic antibody; Hook effect; Pitfall; Specificity

Indexed keywords

CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; INFORMATION PROCESSING; LABORATORY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SHORT SURVEY; VALIDITY;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ENDOCRINOLOGY; HUMANS; IMMUNOASSAY; IMMUNOCHEMISTRY; PROTEIN BINDING;

EID: 55049102336     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2008.04.002     Document Type: Short Survey

References (113)

1. Lepage R., and Albert C. Fifty years of development in the endocrinology laboratory. Clin Biochem 39 (2006) 542-557
2. Klee G.G. Interferences in hormone immunoassays. Clin Lab Med 24 (2004) 1-18
3. Tate J., and Ward G. Interferences in immunoassays. Clin Biochem Rev 25 (2004) 105-120
4. Ismail A.A., Walker P.L., Cawood M.L., and Barth J.H. Interference in immunoassays is an underestimated problem. Ann Clin Biochem 39 (2002) 366-373
5. Yalow R.S., and Berson S.A. Assay of plasma insulin in human subjects by immunological methods. Nature 184 Suppl. 21 (1959) 1648-1649
6. Wolthuis A., and de Vreeze J. Unexpected testosterone result for external quality assessment scheme sample. Clin Chem 51 (2005) 475-476
7. Kivlighan K.T., Granger D.A., Schwartz E.B., Nelson V., Curran M., and Shirtcliff E.A. Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 46 (2004) 39-46
8. Bowen R.A., Vu C., Remaley A.T., Hortin G.L., and Csako G. Differential effect of blood collection tubes on total free fatty acids (FFA) and total triiodothyronine (TT3) concentration: a model for studying interference from tube constituents. Clin Chim Acta 378 (2007) 181-193
9. Selby C. Interference in immunoassay. Ann Clin Biochem 36 (1999) 704-721
10. Snyder J.A., Rogers M.W., King M.S., Phillips J.C., Chapman J.F., and Hammett-Stabler C.A. The impact of hemolysis on ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems. Clin Chim Acta 348 (2004) 181-187
11. Sapin R., Ongagna J.C., Gasser F., and Grucker D. Insulin measurements in haemolysed serum: influence of insulinase inhibitors. Clin Chim Acta 274 (1998) 111-117
12. Sapin R., Schlienger J.L., Grunenberger F., Gasser F., and Chambron J. In vitro and in vivo effects of increased concentrations of free fatty acids on free thyroxin measurements as determined by five assays. Clin Chem 36 (1990) 611-613
13. Strazdins L., Meyerkort S., Brent V., D'Souza R.M., Broom D.H., and Kyd J.M. Impact of saliva collection methods on sIgA and cortisol assays and acceptability to participants. J Immunol Methods 307 (2005) 167-171
14. Talge N.M., Donzella B., Kryzer E.M., Gierens A., and Gunnar M.R. It's not that bad: error introduced by oral stimulants in salivary cortisol research. Dev Psychobiol 47 (2005) 369-376
15. Piketty M.L., Lebtahi R., Dumont A., Chevenne D., and Dilouya A. La réaction croisée en immunoanalyse. Immunoanal Biol Spec 9 (1994) 285-292
16. Murphy B.E. How much "UFC" is really cortisol?. Clin Chem 46 (2000) 793-794
17. ® contraceptive device. Clin Chem Lab Med 46 (2008) 419-420
18. Kasono K., Hikino H., Fujino S., Takemoto N., Kai T., Yamaguchi K., et al. Cross-reactive mechanism for false elevation of free triiodothyronine in patients treated with diclofenac. Endocrinol Jpn 48 (2001) 717-722
19. Middle J.G. Dehydroepiandrostenedione sulphate interferes in many direct immunoassays for testosterone. Ann Clin Biochem 44 (2007) 173-177
20. Wong T., Shackleton C.H., Covey T.R., and Ellis G. Identification of steroids in neonatal plasma that interfere with 17-alpha-hydroxyprogesterone radioimmunoassays. Clin Chem 38 (1992) 1830-1837
21. Jones J.C., Carter G.D., and MacGregor G.A. Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone. Ann Clin Biochem 18 (1981) 54-59
22. Sapin R., Neamtu D., Gasser F., Ohl J., Grunenberger F., and Grucker D. De la prudence lors de l'utilisation des dosages directs de progestérone. Immunoanal Biol Spec 15 (2000) 203-204
23. Bringhurst F.R. Circulating forms of parathyroid hormone: peeling back the onion. Clin Chem 49 (2003) 1973-1975
24. d'Herbomez M., Leclerc L., Vantyghem M.C., Fourrier F., Proye C., and Wemeau J.L. Clinical evaluation of a new sensitive calcitonin assay: study of specificity. Clin Chim Acta 311 (2001) 149-155
25. Slone S.P., Ahmed Z., Cole L.A., Elin R.J., and Martin A.W. Herzig RH et al. Positive pregnancy tests in a nongravid, premenopausal woman due to hCG beta-chain production by multiple myeloma. Am J Clin Pathol 124 (2005) 108-112
26. Cao Z., Swift T.A., West C.A., Rosano T.G., and Rej R. Immunoassay of estradiol: unanticipated suppression by unconjugated estriol. Clin Chem 50 (2004) 160-165
27. Raff H., and Findling J.W. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 35 (1989) 596-600
28. Dhahir F.J., Cook D.B., and Self C.H. Amplified enzyme-linked immunoassay of human proinsulin in serum (detection limit: 0.1 pmol/l). Clin Chem 38 (1992) 227-232
29. McBride J.H., Rodgerson D.O., and Allin R.E. Choriogonadotropin interference in a sensitive assay for thyrotropin. Clin Chem 33 (1987) 1303-1304
30. Paisley A.N., Hayden K., Ellis A., Anderson J., Wieringa G., and Trainer P.J. Pegvisomant interference in GH assays results in underestimation of GH levels. Eur J Endocrinol 156 (2007) 315-319
31. Finco B., Bizzaro N., and Scomparin D. Pitfalls in measuring lutropin by two-site immunoassay with monoclonal antibodies against the intact molecule. Clin Chem 38 (1992) 2159-2160
32. Ferrand V., Niccoli P., Roux F., and Carayon P. Accuracy of luteinizing hormone immunoassay is improved by changing epitope specificity of the labeled monoclonal antibody. Clin Chem 41 (1995) 953-955
33. Mitchell R., Hollis S., Crowley V., McLoughlin J., Peers N., and Robertson W.R. Immunometric assays of luteinizing hormone (LH): differences in recognition of plasma LH by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations. Clin Chem 41 (1995) 1139-1145
34. Hollis B.W. The determination of 25-hydroxy-vitamin D: no easy task. J Clin Endocrinol Metab 89 (2004) 3149-3151
35. Hattori N., Nakayama Y., Kitagawa K., Ishihara T., Saiki Y., and Inagaki C. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia. J Endocrinol 190 (2006) 287-293
36. Spencer C.A., Bergoglio L.M., Kazarosyan M., Fatemi S., and LoPresti J.S. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90 (2005) 5566-5575
37. Ellis A.R., Fahie-Wilson M., Axcell M., Sands K., and Hill R.P. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual serum. Ann Clin Biochem 43 (2006) 57-62
38. Sapin R. Anti-insulin antibodies in insulin immunometric assays: a still possible pitfall. Eur J Clin Chem Clin Biochem 35 (1997) 365-367
39. Amato F., Warnes G.M., Kirby C.A., and Norman R.J. Infertlity caused by HCG autoantibody. J Clin Endocrinol Metab 87 (2002) 993-997
40. Vieira J.G., Nishida S.K., Faria De Camargo M.T., Hauache O.M., Monteiro De Barros Maciel R., and Guimaraes V. "Macro-LH": anomalous molecular form behaves as a complex of luteinizing hormone (LH) and IgG in a patient with unexpected high LH values. Clin Chem 49 (2003) 2104-2105
41. Halsall D.J., Barker P., Prentice A., Chatterjee V.K., and Fahie-Wilson M.N. Macro FSH: elevated serum follicular stimulating hormone (FSH) due to an FSH-IgG complex. Clin Chim Acta 355 Suppl. 1 (2005) S272
42. Cavaco B., Leite V., Loureiro M.M., Ferreira M.F., Pereira M.C., Santos M.A., et al. Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated PTH levels. J Endocrinol Invest 22 (1999) 829-834
43. Sapin R., d'Herbomez M., Schlienger J.L., and Wemeau J.L. Anti-thyrotropin antibody interference in thyrotropin assays. Clin Chem 44 (1998) 2557-2559
44. Halsall D.J., Fahie-Wilson M.N., Hall S.K., Barker P., Anderson J., Gama R., et al. Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother. Clin Chem 52 (2006) 1968-1969
45. Ardill J.E., Larkin C.J., Fillmore D., and Buchanan K.D. Autoantibodies to gastrin in patients with pernicious anaemia - a novel antibody. QJM 91 (1998) 739-742
46. Despres N., and Grant A.M. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 44 (1998) 440-454
47. Kuwahara A., Kamada M., Irahara M., Naka O., Yamashita T., and Aono T. Autoantibody against testosterone in a woman with hypergonadotropic hypogonadism. J Clin Endocrinol Metab 83 (1998) 14-16
48. Grassi J. Interférences dues aux anticorps anti-immunoglobulines, un poison pour tous les dosages immunologiques. I. Origine des anticorps anti-immunoglobulines et mécanisme des interférences. Immunoanal Biol Spec 9 (1994) 60-67
49. Grassi J. Interférences dues aux anticorps anti-immunoglobulines, un poison pour tous les dosages immunologiques. II. Interférences, mise en évidence et suppression. Immunoanal Biol Spec 9 (1994) 124-133
50. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clin Chem 45 (1999) 942-956 Erratum in: Clin Chem 2000; 46: 1722
51. Bjerner J. Human anti-immunoglobulin antibodies interfering in immunometric assays. Scand J Clin Lab Invest 65 (2005) 349-364
52. Lewis J.G., Florkowski C.M., Elder P.A., and Hunt P.J. Rheumatoid factor and false positive sex-hormone binding globulin. Clin Chim Acta 332 (2003) 139-141
53. Kairemo K.J., Kahn J.A., and Taipale P.J. Monoclonal gammopathy may disturb oestradiol measurement in the treatment and monitoring of in-vitro fertilization: case report. Hum Reprod 14 (1999) 2724-2726
54. Covinsky M., Laterza O., Pfeifer J.D., Farkas-Szallasi T., and Scott M.G. An IgM lamda antibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem 46 (2000) 1157-1161
55. Czernichow P., Vandalem J.L., and Hennen G. Transient neonatal hyperthyrotropinemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mother. J Clin Endocrinol Metab 53 (1981) 387-393
56. Boscato L.M., and Stuart M.C. Incidence and specificity of interference in two-site immunoassays. Clin Chem 32 (1986) 1491-1495
57. Reinsberg J. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem 29 (1996) 145-148
58. Stenman U.H. Improving immunoassay performance by antibody engineering. Clin Chem 51 (2005) 801-802
59. Ismail A.A., Walker P.L., Barth J.H., Lewandowski K.C., Jones R., and Burr W.A. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem 48 (2002) 2023-2029
60. Preissner C.M., O'Kane D.J., Singh R.J., Morris J.C., and Grebe S.K. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88 (2003) 3069-3074
61. Cavalier E., Carlisi A., Chapelle J.P., and Delanaye P. False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice. Clin Chim Acta 387 (2008) 150-152
62. Levinson S.S., and Miller J.J. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 325 (2002) 1-15
63. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem 48 (2002) 2008-2016
64. Cole L.A., and Khanlian S.A. Easy fix for clinical laboratories for false-positive defect with the Abbott AxSym total beta-hCG test. Clin Biochem 37 (2004) 344-349
65. Sapin R., Agin A., and Gasser F. Misleading high thyrotropin results obtained with a two-site immunometric assay involving a chimeric antibody. Clin Chem 50 (2004) 946-948
66. Segal D.G., DiMeglio L.A., Ryder K.W., Vollmer P.A., and Pescovitz O.H. Assay interference leading to misdiagnosis of central precocious puberty. Endocrine 20 (2003) 195-199
67. Sapin R., and Simon C. False hyperprolactinemia corrected by the use of heterophilic antibody-blocking agent. Clin Chem 47 (2001) 2184-2185
68. Kasono K., Sato K., Suzuki T., Ohmura E., Demura R., Shizume K., et al. Falsely elevated serum parathyroid hormone levels due to immunoglobulin G in a patient with idiopathic hypoparathyroidism. J Clin Endocrinol Metab 72 (1991) 217-222
69. Papapetrou P.D., Polymeris A., Karga H., and Vaiopoulos G. Heterophilic antibodies causing falsely high serum calcitonin values. J Endocrinol Invest 19 (2006) 919-923
70. Tommasi M., Brocchi A., Cappellini A., Raspanti S., and Mannelli M. False serum calcitonin high levels using a non-competitive two-site IRMA. J Endocrinol Invest 24 (2001) 356-360
71. Giovanella L., Ceriani L., Lumastro C., and Ghelfo A. False-positive serum chromogranin A assay due to heterophile antibody interference. Clin Chim Acta 379 (2007) 171-172
72. Monchamp T., Chopra I.J., Wah D.T., and Butch A.W. Falsely elevated thyroid hormone levels due to anti-sheep antibody interference in an automated electrochemiluminescent immunoassay. Thyroid 17 (2007) 271-275
73. Sapin R., Agin A., and Gasser F. Efficacy of a new blocker against antibody interference in the elecsys free triiodothyronine assay. Clin Chem Lab Med 45 (2007) 416-418
74. Check J.H., Ubelacker L., and Lauer C.C. Falsely elevated steroidal assay levels related to heterophile antibodies against various animal species. Gynecol Obstet Invest 40 (1995) 139-140
75. Ramaeker D, Brannian J, England K, McCaul K, Hansen K. When is elevated testosterone not testosterone? When it is an immunoassay interfering antibody. Fertil Steril 2007 Oct 20; [Epub ahead of print]
76. Luzzi V.I., Scott M.G., and Gronowski A.M. Negative thyrotropin assay interference associated with an IgGkappa paraprotein. Clin Chem 49 (2003) 709-710
77. Giovanella L., and Ghelfo A. Undetectable serum thyroglobulin due to negative interference of heterophile antibodies in relapsing thyroid carcinoma. Clin Chem 53 (2007) 1871-1872
78. Bolland M.J., Chiu W.W., Davidson J.S., and Croxson M.S. Heterophile antibodies may cause falsely lowered serum cortisol values. J Endocrinol Invest 28 (2005) 643-645
79. Banfi G., Pontillo M., Sidoli A., Songini C., and Bonini P. Interference from antiavidin antibodies in thyroid testing in a woman with multiendocrine neoplasia syndrome type 2B. J Clin Ligand Assay 18 (1995) 248-251
80. Henry J.G., Sobki S., and Arafat N. Interference by biotin therapy on measurement of TSH and FT4 by enzymeimmunoassay Boehringer Mannheim ES700 analyzer. Ann Clin Biochem 33 (1996) 162-163
81. Ritter D., Stott R., Grant N., and Nahm M.H. Endogenous antibodies that interfere with thyroxine fluorescence polarization assay but not with radioimmunoassay or EMIT. Clin Chem 39 (1993) 508-511
82. Weber T.H., Kapyaho K.I., and Tanner P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest 201 (1990) 77-82
83. Nelson J.C., and Wilcox R.B. Analytical performance of free and total thyroxine assays. Clin Chem 42 (1996) 146-154
84. Masters A.M., and Hahnel R. Investigation of sex-hormone binding globulin interference in direct radioimmunoassays for testosterone and estradiol. Clin Chem 35 (1989) 979-984
85. Barnes S.C., and Swaminathan R. Effect of albumin concentration on serum cortisol measured by the Bayer Advia Centaur assay. Ann Clin Biochem 44 (2007) 79-82
86. Ekins R. Measurements of free hormones in blood. Endocr Rev 11 (1990) 5-46
87. Swerdloff R.S., and Wang C. Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clin Chim 54 (2008) 458-460
88. Midgley J.E. Direct and indirect free thyroxine assay methods: theory and practice. Clin Chem 47 (2001) 1353-1363
89. Sapin R., and d'Herbomez M. Free thyroxine measured by equilibrium dialysis and nine immunoassays in sera with various serum thyroxine-binding capacities. Clin Chem 49 (2003) 1531-1535
90. Sapin R., Schlienger J.L., Gasser F., Noel E., Lioure B., Grunenberger F., et al. Intermethod discordant free thyroxine measurements in bone marrow-transplanted patients. Clin Chem 46 (2000) 418-422
91. Fernando S.A., and Wilson G.S. Studies of the "hook" effect in the one-step sandwich immunoassay. J Immunol Methods 151 (1992) 47-66
92. Frieze T.W., Mong D.P., and Koops M.K. "Hook effect" in prolactinomas: case report and review of literature. Endocr Pract 8 (2002) 296-303
93. Fleseriu M., Lee M., Pineyro M.M., Skugor M., Reddy S.K., Siraj E.S., et al. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of "hook effect". J Neurooncol 79 (2006) 41-43
94. Tabas J., Strehlow M., and Isaacs E. A false negative pregnancy test in a patient with a hydatidiform molar pregnancy. N Engl J Med 349 (2003) 2172-2195
95. Er T.K., Jong Y.J., Tsai E.M., Huang C.L., Chou H.W., Zheng B.H., et al. False-negative pregnancy test in hydatidiform mole. Clin Chem 52 (2006) 1616-1618
96. Leboeuf R., Langlois M.F., Martin M., Ahnadi C.E., and Fink G.D. "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrinol Metab 91 (2006) 361-364
97. Sapin R., and Schlienger J.L. Ambiguïtés des dosages de thyroglobuline. Ann Biol Clin (Paris) 56 (1998) 41-47
98. Zweig M.H., and Csako G. High-dose hook effect in a two-site IRMA for measuring thyrotropin. Ann Clin Biochem 27 (1990) 494-495
99. Brensing K.A., Dahlmann N., Entzian W., Bidlingmaier F., and Klingmuller D. Underestimation of LH and FSH hormone concentrations in a patient with a gonadotropin secreting tumor: the high-dose "hook-effect" as a methodological and clinical problem. Horm Metab Res 21 (1989) 697-698
100. Garcia-Webb P., Watson F.E., and Whiteside N. "High-dose hook" effect in measurement of somatotropin by two-site immunoradiometric assay. Clin Chem 32 (1986) 2102
101. Anckaert E., Platteau P., Schiettecate J., Devroey P., Van Steirteghem A., and Smitz J. Spuriously elevated serum estradiol concentrations measured by an automated immunoassay rarely cause unnecessary cancellation of in vitro fertilization cycles. Fertil Steril 85 (2006) 1822e.5-8
102. Rotmensch S., and Cole L.A. False positive diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 355 (2000) 712-715
103. Brue T., and Delemer B. et les membres du groupe de travail de la SFE pour le consensus sur les hyperprolactinémies. Diagnostic et prise en charge des hyperprolactinémies : consensus d'experts de la Société française d'endocrinologie (SFE). Ann Endocrinol 68 (2007) 58-64
104. Temple R.C., Clark P.M., Nagi D.K., Schneider A.E., Yudkin J.S., and hales C.N. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol (Oxf) 32 (1990) 689-693
105. Saric T., Seitz H.J., and Pavelic K. Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme. Mol Cell Endocrinol 106 (1994) 23-29
106. Boscaro M., Sonino N., Paoletta A., Rampazzo A., and Mantero F. Evidence for ultra-short loop autoregulation of adrenocorticotropin secretion in man. J Clin Endocrinol Metab 66 (1988) 255-257
107. Winters S.J., Kelley D.E., and Goodpaster B. The analog free testosterone assay: are the results in men clinically useful?. Clin Chem 44 (1998) 2178-2182
108. Jones A.M., and Honour J.W. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol (Oxf) 64 (2006) 234-244
109. Bossuyt X., Verweire K., and Blanckaert N. Laboratory medicine: challenges and opportunities. Clin Chem 53 (2007) 1730-1733
110. Ismail A.A. A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays. Clin Chem 51 (2005) 25-26
111. Bjerner J., Bormer O.P., and Nustad K. The war on heterophilic antibody. Clin Chem 51 (2005) 9-11
112. Diamantis E.P. Immunoassay interference: a relatively rare but still important problem. Clin Biochem 37 (2004) 331-332
113. Sapin R., Le Galudec V., Gasser F., Pinget M., and Grucker D. Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with insulin lispro. Clin Chem 47 (2001) 602-605